Member Info for Elsol

Thx AJP - definitely will review so thank you for the link

Indeed AJP, pocket change for most big speciality chemicals companies growing at meager single digits growth rates. We investors want more than $100m exit though 😃 2026/27 would be a better monetisation outcome for most of us, rather than 2025, unless large acquisition synergies or tech. IP scarcity are at play.

Hi Monte, that's a funny answer 😄 . On the SP consolidation, it just feels comforting having 100,000 shares as opposed to 2,000 shares, although it is counyer intuitive given exactly the same economic ownership in the company . Maybe we will reap wider access benefits into new US investor pools and brokers selling the merits of ITX growth as we exceed $10m revs. and get closer to breakeven? First H1 performance news inbound soon which should help in that regard in light of company CFO messaging and new hiring activity.

Re: staff 2 x production operators ( one night shift) PLUS

2x more accountants ( ops acct. and financial mgt. )

Tells us exactly whats going on in the ITX engine room: manufacturing volumes up, SKUs or formulation types probably up, numbers of discrete clients up. That's all we need to know really...bodes very well for new investors and rerate in 2025

Great, we must have possibility for 3 shifts now 24/7 production staff!

I noticed too but....no worries we knew what you meant $$$$ Medice. Either currency we are still due a major re-rate 😉 to close the asymmetric perception gap toward Broker target of 325p and prof. finance round 255p. When we get toward $10 millions of rev. we start to look more interesting for M&A bolt on so maybe the exit possibilities will drive SP more in H2 2025.

Welcome Arkham! We look forward to your perspectives and input to this board.

With the continued supply chain turbulence and fear of rapid key ingredient supplier cost changes for established brands, I'm expecting 2025 will be bumper year for ITX. In the medium term, key branded formations finance directors and CEOs will be increasing their brand on boarding of raw materials. Gone are just in time supply chain (JIT) models that rely on supply price stability. Hence supply pipeline stocking will drive ITX. Together with price rises we know are in play for ITX, c.10million revenue in FY25 is nailed on IMHO. We will of course see the outcomeof H1 soon, but I'm expecting the volume of stock in the average brand supply chain will be at least 10% fatter than old normal (2024) . Bit like the Covid scenario replaying itself but continues into 2026 with Trump factor in background. DYOR

Thx AJP, once we are formulated into many, many consumer facing brands with ITX formulation advantages it's fantastic as a recurring supply business and difficult to reverse. To be honest that's why I'm here as an investor, I know we all want $20m of revenues this year not $10m as per guidance but the large growth is being delivered under ITX profit strategy 2.0, no matter what the pre existing shareholder gripes are. New investors must see this strong growth (plus M&A buy out possibilities alongside) going forwards and that confirmation will be in mid July or earlier when ITX provide H1 indications and H2 trajectory.

Interesting new line extensions!

We seem to be bobbing along the perimeter of "very cheap" given SP long run history and confirmed performance from CFO and prior tariff mitigation comments from CEO. This will likely remain until H1 2025 outturn is realised with broker analysis and made public...but the volatility looks to be on the upside now for LTSHs.

Hi AJP we may all may be quite surprised on H1 as think that there were significant stockpiling pre tariffs that are probably new normal for 2025. So :

$5m rev is my guess given CFO exceptional commentary which was strange given so early in H1 delivery.

I like the strong marketing messaging on this washing brand majoring on " non toxic" composition, badged centrally on the packaging and very prominent web comms on that point.

At last some initial very positive news in US re: small business litigation against excess reckless tariff policy Still early days but a major fly in the ointment for Trump and Co. and credibility. The ITX incremental price increases may still be in place in future when we get our tariff rebates with interest, which would be a very funny and entertaining result. 😄 . However legal due process going on to Supreme Court or Congress vote or both..?

Hi Chilting - go watch this fascinating inside story from around 1030 today: coverage of Donald Trump's niece, Mary Trump, appearing on UK TV today. On May 23, 2025, Mary Trump was interviewed on the UK morning show This Morning on ITV1, ITVX, and STV. During the interview, she discussed her relationship with her uncle, the impact of the Trump name, and her ongoing public criticism of Donald Trump, highlighting the family feud and legal battles between them. Interesting take on his mind set and inner fragility.

MM tactical price action is crazy and almost criminal at the moment in light of very recent positive mgt messages and broader broker guidance maintained at 325p. My strong advice is hold until the H1 results are delivered since not long to go and will probably hold the FY25 revenue target close to c.$10m and an update on new accounts/channels and profitability expectations for FY26.

Hi Wacca,

I agree the SP has majorly underperformed in the last few years. Amongst other things, this has been due to the internal strategic growth and development transition (**):

1. ITX's pivot to new profit max strategy (ejecton of low profit customer), taking us back c.1 year in breakeven and lowering rev. base c.30%

2. The team capability/NED build out

3. New web site & BD SPARX investment cost

4. Alliances & EU growth platform build

5. Lack of good historical shareholder comms - now hopefully fine given recent CFO stepping up observations and stronger 2024FY Q&A responses a month ago

** These now look to be delivering well for ITX in 2025 but SP appears not to be recognising this yet - perhaps with the fog of macroeconomic uncertainties and wider related investor jitters yet to clear as per Chilting.

However, importantly there have been some large external adverse impacts completely outside of ITX mgt control:

6. Trump reckless tariffs (Black Swan event) with constant resets, up/down, on/off confusion and massive uncertainty that creates for 2025 for all companies

7. Factory roof tornado issue during renovation (slightly Black Swan event)

8. Also post covid investor equity mkts were too frothy and then collapsed back in last few years - too much circulating money chasing share prices up prematurely then dumped.

Where are we now?

As per Smartinvestor I agree floor is about 2p old money and £1 today. My comment about hypothetical base value of assets in orderly liquidation supports this as rock bottom but to be absolutely clear to everyone here its a "hypothetical scenario" not a real scenario, but helps rationalise where the current share price is (e.g. v. low) compared to possible SP upside and where it may go with further good trading to be confirmed in July (H1). I agree some investors still feel very cautious but ITX seems to be delivering strong revenue growth and on cusp of commercial success and profitability- so let's await near term catalysts before throwing the baby out with the bathwater and criticising mgt team harshly since they have accomplished alot in the last 2 years strategically and commercially is my honest opinion.

JD - Existing share option stakes and cost of living crisis for everyone including Directors.

Shareholders can make more in a hypothetical orderly liquidation of ITX contracts, relationships and IP & cash assets than the current SP Wacca that's the important point here. Its hardly over valued my friend but you assume I'm being too optimistic on fair value.

Anyone with free cash - its time to fill your boots as we head towards $10m revenues this year (almost half way now to full FY25 and with H1 readout looming now and knowing recent CFO's bullish commentary on streamed live video)!